Stay updated on Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.

Latest updates to the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page
- Check5 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check12 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check19 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check26 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check47 days agoChange DetectedAccess to the study record page now displays a 403 Forbidden error, including the 403 HTML header. The previous study content is no longer accessible and has been replaced by the error page.SummaryDifference23%

- Check68 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6. This indicates a minor metadata update to the study page rather than changes to its substantive content.SummaryDifference0.0%

Stay in the know with updates to Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.